Short answer · Medically reviewed summary · Last updated: 2026-04-07
Lesch-Nyhan syndrome is a rare, inherited metabolic disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), which leads to an overproduction of uric acid in the body. The condition primarily affects the nervous system and kidneys, resulting in a combination of movement disorders, cognitive impairment, and severe self-injurious behavior. What are the primary symptoms and body systems affected by Lesch-Nyhan syndrome? Lesch-Nyhan syndrome is characterized by a triad of clinical features: neurological dysfunction, behavioral challenges, and metabolic abnormalities.
Lesch-Nyhan syndrome is a rare, inherited metabolic disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), which leads to an overproduction of uric acid in the body. The condition primarily affects the nervous system and kidneys, resulting in a combination of movement disorders, cognitive impairment, and severe self-injurious behavior.
Lesch-Nyhan syndrome is characterized by a triad of clinical features: neurological dysfunction, behavioral challenges, and metabolic abnormalities. Because the HPRT enzyme is essential for recycling purines (the building blocks of DNA and RNA), its absence causes uric acid to build up to toxic levels. This leads to the formation of urate crystals, which can cause gouty arthritis, kidney stones, and severe kidney damage. Neurologically, Lesch-Nyhan syndrome manifests as dystonia (involuntary muscle contractions), choreoathetosis (jerky, involuntary movements), and spasticity. One of the most distinct and challenging symptoms of Lesch-Nyhan syndrome is compulsive self-injury, which often includes biting of the lips, tongue, and fingers.
Lesch-Nyhan syndrome is an X-linked recessive disorder, meaning it almost exclusively affects males. Because the gene responsible (HPRT1) is located on the X chromosome, a mother who carries the gene mutation has a 50% chance of passing it to her sons. While the condition is extremely rare—estimated to affect approximately 1 in 235,000 to 1 in 380,000 live births—it occurs worldwide across all ethnic populations. Symptoms typically appear in early infancy, often within the first 3 to 6 months of life, as parents observe developmental delays and the presence of orange-colored "sand" (urate crystals) in the child's diapers.
While many metabolic conditions involve developmental delay, Lesch-Nyhan syndrome is uniquely identified by the specific combination of uric acid overproduction and the neurological profile. Distinguishing features include:
Yes, there is a spectrum of HPRT-related disorders. While the "classic" Lesch-Nyhan syndrome includes the severe neurological and behavioral symptoms mentioned above, some individuals have partial HPRT deficiency. Those with partial deficiency may develop gout and kidney stones (nephrolithiasis) without the severe neurological or self-injurious behaviors. Our community at DiseaseMaps.org includes 78 people with Lesch-Nyhan syndrome, representing a range of experiences across this clinical spectrum.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition.